{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:35:48Z","timestamp":1790224548516,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T00:00:00Z","timestamp":1445385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T00:00:00Z","timestamp":1445385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/gt.2015.101","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T14:41:27Z","timestamp":1445438487000},"page":"144-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Gene transfer of two entry inhibitors protects CD4+ T cell from HIV-1 infection in humanized mice"],"prefix":"10.1038","volume":"23","author":[{"given":"N Y","family":"Petit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Baillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Burlion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Dorgham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Levacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Amiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F M","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gorochov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4889-6785","authenticated-orcid":false,"given":"G","family":"Marodon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,21]]},"reference":[{"key":"BFgt2015101_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ng0597-100","volume":"16","author":"JJ Martinson","year":"1997","unstructured":"Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB . Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997; 16: 100\u2013103.","journal-title":"Nat Genet"},{"key":"BFgt2015101_CR2","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","volume":"117","author":"K Allers","year":"2011","unstructured":"Allers K, H\u00fctter G, Hofmann J, Loddenkemper C, Rieger K, Thiel E et al. Evidence for the cure of HIV infection by CCR5\u039432\/\u039432 stem cell transplantation. Blood 2011; 117: 2791\u20132799.","journal-title":"Blood"},{"key":"BFgt2015101_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nbt.1663","volume":"28","author":"N Holt","year":"2010","unstructured":"Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V et al. Human hematopoietic stem\/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010; 28: 839\u2013847.","journal-title":"Nat Biotechnol"},{"key":"BFgt2015101_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood-2013-08-521229","volume":"123","author":"CA Didigu","year":"2014","unstructured":"Didigu CA, Wilen CB, Wang J, Duong J, Secreto AJ, Danet-Desnoyers GA et al. Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. Blood 2014; 123: 61\u201369.","journal-title":"Blood"},{"key":"BFgt2015101_CR5","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nbt1410","volume":"26","author":"EE Perez","year":"2008","unstructured":"Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 2008; 26: 808\u2013816.","journal-title":"Nat Biotechnol"},{"key":"BFgt2015101_CR6","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1056\/NEJMoa1300662","volume":"370","author":"P Tebas","year":"2014","unstructured":"Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 2014; 370: 901\u2013910.","journal-title":"N Engl J Med"},{"key":"BFgt2015101_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/gt.2012.98","volume":"20","author":"CW Peterson","year":"2013","unstructured":"Peterson CW, Younan P, Jerome KR, Kiem H-P . Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART. Gene Ther 2013; 20: 695\u2013702.","journal-title":"Gene Ther"},{"key":"BFgt2015101_CR8","doi-asserted-by":"publisher","first-page":"9475","DOI":"10.1073\/pnas.1222205110","volume":"110","author":"P Colin","year":"2013","unstructured":"Colin P, B\u00e9nureau Y, Staropoli I, Wang Y, Gonzalez N, Alcami J et al. HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines. Proc Natl Acad Sci USA 2013; 110: 9475\u20139480.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2015101_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/jac\/dkh330","volume":"54","author":"ML Greenberg","year":"2004","unstructured":"Greenberg ML, Cammack N . Resistance to enfuvirtide, the first HIV fusion inhibitor. J Antimicrob Chemother 2004; 54: 333\u2013340.","journal-title":"J Antimicrob Chemother"},{"key":"BFgt2015101_CR10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/jgm.908","volume":"8","author":"D Von Laer","year":"2006","unstructured":"Von Laer D, Hasselmann S, Hasselmann K . Gene therapy for HIV infection: what does it need to make it work? J Gene Med 2006; 8: 658\u2013667.","journal-title":"J Gene Med"},{"key":"BFgt2015101_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nature12940","volume":"505","author":"G Doitsh","year":"2014","unstructured":"Doitsh G, Galloway NLK, Geng X, Yang Z, Monroe KM, Zepeda O et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014; 505: 509\u2013514.","journal-title":"Nature"},{"key":"BFgt2015101_CR12","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/QAD.0b013e32815278ea","volume":"21","author":"A Heredia","year":"2007","unstructured":"Heredia A, Gilliam B, DeVico A, Le N, Bamba D, Flinko R et al. CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1. Aids 2007; 21: 1317\u20131322.","journal-title":"Aids"},{"key":"BFgt2015101_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.virol.2012.03.008","volume":"428","author":"CG Anastassopoulou","year":"2012","unstructured":"Anastassopoulou CG, Ketas TJ, Sanders RW, Klasse PJ, Moore JP . Effects of sequence changes in the HIV-1 gp41 fusion peptide on CCR5 inhibitor resistance. Virology 2012; 428: 86\u201397.","journal-title":"Virology"},{"key":"BFgt2015101_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1089\/hgtb.2014.034","volume":"25","author":"N Petit","year":"2014","unstructured":"Petit N, Dorgham K, Levacher B, Burlion A, Gorochov G, G Marodon . Targeting both viraland host determinants of human immunodeficiency virus entry, using a new lentiviral vector coexpressing the T20 fusion inhibitor and a selective CCL5 intrakine. Hum Gene Ther Methods 2014; 25: 232\u2013240.","journal-title":"Hum Gene Ther Methods"},{"key":"BFgt2015101_CR15","doi-asserted-by":"publisher","first-page":"6637","DOI":"10.1128\/JVI.77.12.6637-6644.2003","volume":"77","author":"O Hartley","year":"2003","unstructured":"Hartley O, Dorgham K, Perez-Bercoff D, Cerini F, Heimann A, Gaertner H et al. Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines. J Virol 2003; 77: 6637\u20136644.","journal-title":"J Virol"},{"key":"BFgt2015101_CR16","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/sj.gt.3301711","volume":"9","author":"R Schroers","year":"2002","unstructured":"Schroers R, Davis CM, Wagner HJ, Chen SY . Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection. Gene Ther 2002; 9: 889\u2013897.","journal-title":"Gene Ther"},{"key":"BFgt2015101_CR17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1128\/JVI.78.2.568-575.2004","volume":"78","author":"M Egelhofer","year":"2004","unstructured":"Egelhofer M, Brandenburg G, Martinius H, Schult-Dietrich P, Melikyan G, Kunert R et al. Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides. J Virol 2004; 78: 568\u2013575.","journal-title":"J Virol"},{"key":"BFgt2015101_CR18","doi-asserted-by":"publisher","first-page":"e12357","DOI":"10.1371\/journal.pone.0012357","volume":"5","author":"J Kimpel","year":"2010","unstructured":"Kimpel J, Braun SE, Qiu G, Wong FE, Conolle M, Schmitz JE et al. Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection. PLoS One 2010; 5: e12357.","journal-title":"PLoS One"},{"key":"BFgt2015101_CR19","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.1038\/mtna.2015.10","volume":"4","author":"BP Burke","year":"2015","unstructured":"Burke BP, Levin BR, Zhang J, Sahakyan A, Boyer J, Carroll MV et al. Engineering cellular resistance to HIV-1 infection in vivo using a dual therapeutic lentiviral vector. Mol Ther Acids 2015; 4: e236.","journal-title":"Mol Ther Acids"},{"key":"BFgt2015101_CR20","doi-asserted-by":"publisher","first-page":"e7693","DOI":"10.1371\/journal.pone.0007693","volume":"4","author":"GD Trobridge","year":"2009","unstructured":"Trobridge GD, Wu RA, Beard BC, Chiu SY, Mu\u00f1oz NM, von Laer D et al. Protection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection. PLoS One 2009; 4: e7693.","journal-title":"PLoS One"},{"key":"BFgt2015101_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2249.2009.03933.x","volume":"157","author":"MA King","year":"2009","unstructured":"King MA, Covassin L, Brehm MA, Racki W, Pearson T, Leif J et al. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 2009; 157: 104\u2013118.","journal-title":"Clin Exp Immunol"},{"key":"BFgt2015101_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1182\/blood-2013-01-482224","volume":"122","author":"PM Younan","year":"2013","unstructured":"Younan PM, Polacino P, Kowalski JP, Peterson CW, Maurice NJ, Williams NP et al. Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model. Blood 2013; 122: 179\u2013187.","journal-title":"Blood"},{"key":"BFgt2015101_CR23","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1038\/mtna.2015.3","volume":"4","author":"S Shimizu","year":"2015","unstructured":"Shimizu S, Ringpis G-E, Marsden MD, Cortado RV, Wilhalme HM, Elashoff D et al. RNAi-mediated CCR5 knockdown provides HIV-1 resistance to memory T cells in humanized BLT mice. Mol Ther Nucleic Acids 2015; 4: e227.","journal-title":"Mol Ther Nucleic Acids"},{"key":"BFgt2015101_CR24","doi-asserted-by":"publisher","first-page":"6761","DOI":"10.1128\/JVI.00277-15","volume":"89","author":"R Myburgh","year":"2015","unstructured":"Myburgh R, Ivic S, Pepper MS, Gers-Huber G, Li D, Audig\u00e9 A et al. Lentivector knock-down of CCR5 in hematopoietic stem cells confers functional and persistent HIV-1 resistance in humanized mice. J Virol 2015; 89: 6761\u20136772.","journal-title":"J Virol"},{"key":"BFgt2015101_CR25","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1128\/JVI.06300-11","volume":"86","author":"JE Walker","year":"2012","unstructured":"Walker JE, Chen RX, McGee J, Nacey C, Pollard RB, Abedi M et al. Generation of an HIV-1-resistant immune system with CD34+ hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector. J Virol 2012; 86: 5719\u20135729.","journal-title":"J Virol"},{"key":"BFgt2015101_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/mt.2013.296","volume":"22","author":"SS De Ravin","year":"2014","unstructured":"De Ravin SS, Gray JT, Throm RE, Spindler J, Kearney M, Wu X et al. False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector. Mol Ther 2014; 22: 244\u2013245.","journal-title":"Mol Ther"},{"key":"BFgt2015101_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2174\/156652321405140926161748","volume":"14","author":"C Abarrategui-Pontes","year":"2014","unstructured":"Abarrategui-Pontes C, Cr\u00e9neguy A, Thinard R, Fine EJ, Thepenier V, Fournier LRL et al. Codon swapping of zinc finger nucleases confers expression in primary cells and in vivo from a single lentiviral vector. Curr Gene Ther 2014; 14: 365\u2013376.","journal-title":"Curr Gene Ther"},{"key":"BFgt2015101_CR28","doi-asserted-by":"publisher","first-page":"36ra43","DOI":"10.1126\/scitranslmed.3000931","volume":"2","author":"DL DiGiusto","year":"2010","unstructured":"DiGiusto DL, Krishnan A, Li L, Li H, Li S, Rao A et al. RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med 2010; 2: 36ra43.","journal-title":"Sci Transl Med"},{"key":"BFgt2015101_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ymthe.2005.02.024","volume":"12","author":"GM Podsakoff","year":"2005","unstructured":"Podsakoff GM, Engel BC, Carbonaro DA, Choi C, Smogorzewska EM, Bauer G et al. Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34+ cells. Mol Ther 2005; 12: 77\u201386.","journal-title":"Mol Ther"},{"key":"BFgt2015101_CR30","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","volume":"98","author":"R Zufferey","year":"1998","unstructured":"Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 98: 9873\u20139880.","journal-title":"J Virol"},{"key":"BFgt2015101_CR31","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1182\/blood-2002-02-0578","volume":"101","author":"G Marodon","year":"2003","unstructured":"Marodon G, Mouly E, Blair EJ, Frisen C, Lemoine FM, Klatzmann D . Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene. Blood 2003; 101: 3416\u20133423.","journal-title":"Blood"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt2015101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2015101","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2015101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:09:04Z","timestamp":1648555744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt2015101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,21]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFgt2015101"],"URL":"https:\/\/doi.org\/10.1038\/gt.2015.101","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,21]]},"assertion":[{"value":"19 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}